Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

finance.yahoo.com/news/quest-diagnostics-raises-outlook-warns-171048734.html

In This Article:
Quest Diagnostics Inc. (NYSE:DGX) delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales and earnings growth, prompting an upward revision to its full-year guidance.
However, the diagnostic test provider flagged potential headwinds…

This story appeared on finance.yahoo.com, 2025-07-22 17:10:48.
The Entire Business World on a Single Page. Free to Use →